• Users Online: 622
  • Home
  • Print this page
  • Email this page

   Table of Contents      
Year : 2018  |  Volume : 66  |  Issue : 2  |  Page : 207-211

Prevalence and risk factors of dry eye disease in North India: Ocular surface disease index-based cross-sectional hospital study

Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India

Date of Submission07-Aug-2017
Date of Acceptance16-Nov-2017
Date of Web Publication30-Jan-2018

Correspondence Address:
Dr. Jeewan Singh Titiyal
Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, Ansari Nagar, New Delhi - 110 029
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ijo.IJO_698_17

Rights and Permissions

Purpose: This study aims to study the prevalence of DED and analyze risk factors in North Indian population. Methods: This was a cross-section hospital-based, observational study. Cases enrolled over 2 years (systematic random sampling) were administered ocular surface disease index questionnaire to evaluate the prevalence and risk factors of DED. Schirmer's test and tear break-up time were performed only in the subset of patients giving consent. Categorical data were assessed with Chi-square/Fisher's Exact test, and odds ratio was analyzed using bivariate and multivariate logistic regression. P < 0.05 was statistically significant. Results: A total of 15,625 patients were screened. The prevalence of DED was 32% (5000/15625); 9.9% (496/5000) had mild DED; 61.2% (3060/5000) had moderate DED; and 28.9% (1444/5000) had severe DED. Age group of 21–40 years, male sex, urban region, and desk job were associated with increased risk of DED. Hours of visual display terminal (VDT) usage significantly correlated with DED (P < 0.001), and 89.98% of patients with 4 h or more of VDT use had severe dry eye. Cigarette smoking and contact lens usage had increased odds of developing severe DED (P < 0.001). Objective tests were undertaken in 552 patients; of these, 81.3% (449/552) had severe DED. Conclusions: The prevalence of DED in North India is 32%, with the age group of 21–40 years affected most commonly. VDT use, smoking, and contact lens use were associated with increased odds of developing DED.

Keywords: Dry eye disease, North India, visual display terminal

How to cite this article:
Titiyal JS, Falera RC, Kaur M, Sharma V, Sharma N. Prevalence and risk factors of dry eye disease in North India: Ocular surface disease index-based cross-sectional hospital study. Indian J Ophthalmol 2018;66:207-11

How to cite this URL:
Titiyal JS, Falera RC, Kaur M, Sharma V, Sharma N. Prevalence and risk factors of dry eye disease in North India: Ocular surface disease index-based cross-sectional hospital study. Indian J Ophthalmol [serial online] 2018 [cited 2023 Dec 3];66:207-11. Available from: https://journals.lww.com/ijo/pages/default.aspx/text.asp?2018/66/2/207/224096

Dry eye disease (DED) is a chronic ocular pathology and a major global health problem that manifests as a plethora of symptoms such as burning, photophobia, tearing, and grittiness. Patients with DED experience difficulties in daily routine activities thus compromising their quality of life.[1]

The subjective symptoms and discomfort experienced by the patients with DED poorly correlates with the objective clinical tests.[2] The diagnosis and grading of DED on the basis of symptom-based questionnaires such as the ocular surface disease index (OSDI) questionnaire (Allergen Inc, Irvine, Calif, USA) is more reliable than based on clinical tests.[2],[3],[4],[5]

The prevalence of DED is greatly influenced by geographic location, climatic conditions, and lifestyle of the people and ranges from 5% to 35%.[6],[7],[8] However, different definitions of dry eye are employed in various epidemiological studies which may not be standardized, and limited data exist on the potential effect of race or ethnicity on dry eye prevalence. There is a need to expand epidemiological studies to more geographic regions using standardized questionnaires and uniform diagnostic criteria. Very few studies have described the epidemiology of DED from the Indian subcontinent.[9],[10],[11],[12],[13] We describe the prevalence of DED and the demographic profile of individuals with DED reporting to a tertiary care center in North India.

  Methods Top

A cross-section hospital-based, observational study was conducted at an apex tertiary care ophthalmic institution. Patients presenting to the outdoor patient department over a period of 2 years (June 2014–May 2016) were evaluated. Ethical clearance was obtained from the Institutional Review Board. Informed consent was obtained, and the study adhered to the tenets of the Declaration of Helsinki.

Systematic random sampling was performed to enroll patients, wherein the first patient was selected randomly, and subsequently, every fifth patient was enrolled in the study. All consenting patients above 10 years of age were included in the study and divided into four groups based on age: ≤20 years, 21–40 years, and >40 years. Patients younger than 10 years or not providing consent were excluded from the study.

Verbal informed consent was obtained before administering the OSDI score. Written informed consent was obtained only from patients willing to undergo objective tests.

The primary objective of the study was to analyze the prevalence of symptomatic DED based on the OSDI questionnaire and to analyze the associated risk factors. The secondary objective was to assess the tear film stability and secretion in patients with symptoms of DED.

Comprehensive history was obtained from all the patients with emphasis on history pertaining to dry eye. In addition, history of visual display terminals (VDT) usage including television, smartphones, tablets, laptops, etc., was also elicited and analyzed.

OSDI questionnaire was administered to all patients. The questionnaire was administered by a single examiner. To those who were nonconversant in English, the questions were explained to the patients in their local language. The OSDI questionnaire has 12 items, with each question given a score ranging from 0 (none of the time) to 4 (all of the time). The patients had to assign a score based on the duration of symptoms experienced over the preceding week. The final score was calculated by multiplying the sum of all the scores by 25 and then dividing the total by the number of questions answered. Scores range from 0 to 100 with 0–12 representing normal, 13–22 representing mild DED, 23–32 representing moderate DED, and ≥33 representing severe DED.[5],[14]

The objective tests were undertaken only in patients with DED (based on the OSDI questionnaire) who gave consent for further investigations. These patients underwent tear film break up time (TBUT) and Schirmer test. The tests were carried out in the same room by a single examiner, with similar temperature and humidity conditions for all patients. The room temperature was maintained at 25°C–26.5°C, with 60%–65% humidity during examination.

Tear break up time

Fluorescein was applied to the ocular surface. The patient was asked to blink a few times before examination. Slit lamp biomicroscopy with a cobalt blue filter was used to investigate the tear film layer, and the interval from the last blink to the appearance of the first random dry spot on the cornea was noted. The test was repeated thrice and the mean value was calculated. Value of <10 s was considered as indicative of tear film instability.[15]

Schirmer's test

Whatman filter paper no 41 (measuring 5 mm × 35 mm) was placed in the lower fornix at the lateral one-third of the lower lid margin. The extent of wetting of the strip was measured after 5 min. Less than 5.5 mm of wetting was diagnostic of severe dry eye.[16] Schirmer's test was done without anesthesia. To avoid the influence of conjunctiva-corneal staining on the Schirmer test, it was carried out at an interval of 10 min after the TBUT test.

Statistical analysis

The data were analyzed using Stata 14.0 (StataCorp LP, College Station, TX, USA). Chi-square test/Fischer Exact test were used to establish the association between categorical data. Bivariate logistic regression analysis was used to calculate the odds ratio (OR). Multivariate analysis was performed to identify independent risk factors. P < 0.05 was considered statistically significant.

No formal sample size calculation was done. As per statistical experts, at least 10 subjects per potential risk factor should be enrolled to constitute an adequate sample size for risk factor studies. We have studied only 19 potent risk factors in our study, and the sample size is more than adequate to estimate the strength of association for each risk factor.

  Results Top

A total of 15625 patients were administered the OSDI questionnaire over a period of 2 years, and their demographic profile is elaborated in [Table 1]. Clinically, significant DED was detected in 32% (5000/15,625) patients. Of these, 9.9% (496/5000) had mild DED, 61.2% (3060/5000) had moderate DED, and 28.9% (1444/5000) had severe DED. The demographic details of the patients with DED are described in [Table 2]. The OSDI questionnaire consists of 12 questions, and 66% (3300/5000) answered all 12 questions, whereas 1.58% (79/5000) answered 11 questions, 32.34% (1617/5000) answered 10 questions, and 0.08% (4/5000) answered 9 questions. The mean OSDI scores were 20.59 ± 1.14 in cases with mild DED, 28.60 ± 2.68 in cases with moderate DED and 42.32 ± 7.82 in cases with severe DED. The scores for the three domains of OSDI, namely, ocular symptoms, vision-related functions, and environmental triggers is summarized in [Table 3].
Table 1: Demographic profile of 15,625 patients who were administered the Ocular Surface Disease Index questionnaire

Click here to view
Table 2: Demographic profile of patients presenting with dry eye disease to a tertiary care ophthalmic setup

Click here to view
Table 3: Mean Ocular Surface Disease Index scores and domain scores in patients with dry eye disease

Click here to view

The prevalence of DED was more in males (65.3% males, 34.7% females) and in patients between 21 and 40 years of age (52.1%). Majority of patients belonged to the urban areas (65.02%) as compared to a rural background (34.98%). Patients involved in desk jobs with computer use were more predisposed to develop DED.

A bivariate analysis of the risk factors associated with the development of severe DED as well as a multivariate analysis of risk factors associated with DED was undertaken. Significant odds of having severe DED were associated with age, occupation, VDT use, cigarette smoking, and contact lens use [Table 4].
Table 4: Bivariate and multivariate analysis of factors associated with severity of dry eye disease

Click here to view

There was no significant difference in the severity of the disease between males and females (P = 0.18). Occupation involving desk job with regular computer usage was associated with the development of dry eye, with 89.47% of computer users having severe DED. Hours of video display terminal (including computers, television, and mobile phone screens) usage significantly correlated with DED (P< 0.001), and 89.98% patients with 4 h or more of VDT use had severe dry eye (adjusted OR 60.2; 95% confidence interval [CI] 43.9–82.7).

Cigarette smoking (P< 0.001, OR 1.5; 95% CI 1.19–1.88) and contact lens usage (P< 0.001, OR 6.4; 95% CI 3.31–12.65) were identified as significant risk factors for severe DED.

There was no significant association between severe DED and the presence of systemic disease, systemic or ocular allergy, previous ocular surgery, alcohol intake or any systemic, or topical medications including steroid use.

Objective tests were undertaken in 552 patients (1104 eyes) with DED. Of these, 18.65% (103/552) had nonsevere DED (mild and moderate), and the remaining 81.3% (449/552) had severe DED. The mean Schirmer's test values were 25.0 ± 8.4 mm in cases with mild DED, 16.9 ± 6.6 mm in cases with moderate DED, and 14.5 ± 7.1 mm in cases with severe DED. The mean TBUT was 10.5 ± 1.6 s in cases with mild DED, 7.1 ± 2.0 s in cases with moderate DED and 4.9 ± 2.3 s in cases with severe DED. A Schirmer's test value of <5.5 mm (indicative of severe DED) was observed in only 5.3% cases (58 eyes). TBUT of <10 s (indicative of tear film instability) was observed in 95.8% cases (1058 eyes).

  Discussion Top

DED is one of the most prevalent ophthalmic disorders and may have an adverse impact on the quality of life. In addition to causing various disabling symptoms, it may also compromise the results of the corneal, cataract, and refractive surgical procedures.

Several objective tests have been developed to diagnose and grade the severity of DED. However, these tests show poor repeatability, significant interobserver variability and correlate poorly with the patient symptoms as well as the quality of life.[2],[3],[4] Different patient-reported outcome (PRO) questionnaires have been developed to assess the quality of life in patients with DED, which act as a useful tool to aid in the screening, monitoring, and management of DED.[5],[17] Two validated, reliable dry eye questionnaires are currently available that are in accordance with the FDA PRO guidelines: OSDI and the impact of dry eye on everyday life questionnaire.[5],[17],[18],[19],[20] In our study, we used the OSDI questionnaire as the basic tool for screening the patients. Its shorter completion time, easy comprehension by patients, and no additional cost make it ideal for clinical use in the outpatient department.[5],[20]

The prevalence of dry eye in our study based on OSDI questionnaire is 32%. The prevalence of DED in India is higher than the global prevalence and ranges from 18.4% to 54.3%.[9],[13] The vast disparity in the prevalence of DED may be attributed to endemic geographic variations as well as the use of different diagnostic criteria by various studies. Moreover, we relied on only symptoms to estimate the prevalence of DED, which may have resulted in an overestimation of the prevalence of DED.

In our study, the majority of patients with DED were in the age group of 21–40 years. The previous epidemiological studies often exclude this age group, and may, therefore, have underestimated the true prevalence of DED.[6],[9],[10] A selection bias toward the younger population cannot be ruled out, as the older population visiting the hospital for ocular pathologies such as cataract is less likely to consent to answering the questionnaire.

Females are affected more commonly than males in a majority of studies.[6],[7],[8],[9],[10],[11],[12],[13] We observed a significantly higher occurrence of DED in males. Since ours was a hospital-based study, this trend could be attributed to the lack of treatment-seeking behavior among females in the developing countries. The Salisbury Eye Evaluation study also reported males to be more commonly affected than females; however, it included only patients more than 65 years of age.[21]

Desk job with computer use was significantly associated with the risk of developing severe DED. The low-relative humidity in indoor office environment and air-conditioned rooms negatively impacts the tear film by causing desiccation of the eye. We observed a strong association between VDT usage and severe DED. Computer use for more than 8 h a day has been reported as a significant risk factor for DED, mainly attributed to the decrease in blink rate while using these devices, thereby hampering the uniform distribution of the tear film over the ocular surface.[22] Since the main route of tear elimination is through evaporation, longer periods of eye opening and the higher gaze angle when viewing a computer screen results in faster tear loss which further worsens the dry eye. We observed 89.98% of dry eye cases with 4 h or more of VDT usage had severe DED. Increasing use of computers, laptops, tablets, smartphones and television has led to an increase in the prevalence of DED in the younger population.

We observed a significant association of DED with contact lens usage as well as smoking. Contact lens usage may cause dry eye or aggravate preexisting DED.[23],[24] Nearly 50% of contact lens users may complain of symptoms of dryness, discomfort, grittiness, irritation, burning, or foreign body sensation.[23],[24] Smoking may affect the tear film stability as well as ocular surface sensitivity, and a significant association has been reported between smoking and DED.[25]

We did not observe any association with systemic comorbidities, allergies, previous ocular surgery, alcohol or medication use, either systemic or topical.

Only 552 patients consented to undergo objective tests for the evaluation of DED. The patients answering the questionnaire were visiting the hospital for a specific ocular purpose and were less likely to consent for contact examination after answering the questionnaire. The prevalence of severe dry eye was found to be 81.3%% in this subgroup as against 28.88% when classified on the basis of questionnaire. This may be explained on the basis that patients with severe DED were more likely to give consent for further invasive clinical tests as compared to patients with mild-moderate DED. This further highlights the superiority of questionnaires over objective tests as a screening tool for DED. A Schirmer's test value of < 5.5 mm (indicative of severe DED) was observed in only 5.3% cases (58 eyes), and the mean Schirmer's test value was more than 10 mm in all severity grades of DED. This may be a result of reflex tearing during the examination and is also indicative of less prevalence of aqueous tear deficiency type dry eye in our study. A tear-film instability was observed in 95.8% patients with DED. A mean TBUT of 10 s or more was observed in cases with mild TBUT, which may indicate an overestimation of the prevalence of DED by the OSDI questionnaire.

The inherent bias associated with hospital-based studies is a limitation of our study. Rural population staying in far-flung areas with limited access to healthcare, females and elderly are less likely to visit the hospital due to sociocultural environment prevalent in developing nations. Moreover, the patients had come for specific reasons mostly not pertaining to DED, and these patients were usually not willing to undergo further examination.

To the best of our knowledge, ours is one of the largest studies which screened 15625 individuals and identified the presence of DED in 5000 individuals based on a validated subjective questionnaire. We included all patients more than 10 years of age. Majority of epidemiology studies have included patients more than 40 years of age.[6],[9],[10] However, with the increasing use of VDT by the younger age group, specifically teenagers, there is a need for the epidemiological studies to broaden their inclusion criteria to obtain an accurate estimate of the prevalence of DED.

  Conclusions Top

We observed the prevalence of DED in North India to be 32%, with the age group of 21–40 years affected most commonly. VDT use, smoking, and contact lens use were associated with increased odds of developing DED.

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.

  References Top

Miljanović B, Dana R, Sullivan DA, Schaumberg DA. Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol 2007;143:409-15.  Back to cited text no. 1
Nichols KK, Mitchell GL, Zadnik K. The repeatability of clinical measurements of dry eye. Cornea 2004;23:272-85.  Back to cited text no. 2
Begley CG, Chalmers RL, Abetz L, Venkataraman K, Mertzanis P, Caffery BA, et al. The relationship between habitual patient-reported symptoms and clinical signs among patients with dry eye of varying severity. Invest Ophthalmol Vis Sci 2003;44:4753-61.  Back to cited text no. 3
Kallarackal GU, Ansari EA, Amos N, Martin JC, Lane C, Camilleri JP, et al. Acomparative study to assess the clinical use of fluorescein meniscus time (FMT) with tear break up time (TBUT) and Schirmer's tests (ST) in the diagnosis of dry eyes. Eye (Lond) 2002;16:594-600.  Back to cited text no. 4
Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the ocular surface disease index. Arch Ophthalmol 2000;118:615-21.  Back to cited text no. 5
The epidemiology of dry eye disease: Report of the Epidemiology Subcommittee of the International Dry Eye Workshop (2007). Ocul Surf 2007;5:93-107.  Back to cited text no. 6
McCarty CA, Bansal AK, Livingston PM, Stanislavsky YL, Taylor HR. The epidemiology of dry eye in Melbourne, Australia. Ophthalmology 1998;105:1114-9.  Back to cited text no. 7
Lin PY, Tsai SY, Cheng CY, Liu JH, Chou P, Hsu WM, et al. Prevalence of dry eye among an elderly Chinese population in Taiwan: The Shihpai eye study. Ophthalmology 2003;110:1096-101.  Back to cited text no. 8
Gupta N, Prasad I, Jain R, D'Souza P. Estimating the prevalence of dry eye among Indian patients attending a tertiary ophthalmology clinic. Ann Trop Med Parasitol 2010;104:247-55.  Back to cited text no. 9
Basak SK, Pal PP, Basak S, Bandyopadhyay A, Choudhury S, Sar S, et al. Prevalence of dry eye diseases in hospital-based population in West Bengal, Eastern India. J Indian Med Assoc 2012;110:789-94.  Back to cited text no. 10
Rege A, Kulkarni V, Puthran N, Khandgave T. A clinical study of subtype-based prevalence of dry eye. J Clin Diagn Res 2013;7:2207-10.  Back to cited text no. 11
Sahai A, Malik P. Dry eye: Prevalence and attributable risk factors in a hospital-based population. Indian J Ophthalmol 2005;53:87-91.  Back to cited text no. 12
[PUBMED]  [Full text]  
Shah S, Jani H. Prevalence and associated factors of dry eye: Our experience in patients above 40 years of age at a tertiary care center. Oman J Ophthalmol 2015;8:151-6.  Back to cited text no. 13
[PUBMED]  [Full text]  
Walt JG, Rowe MM, Stern KL. Evaluating the functional impact of dry eye: The ocular surface disease index. Drug Inf J 1997;31:1436.  Back to cited text no. 14
Lemp MA, Hamill JR Jr. Factors affecting tear film breakup in normal eyes. Arch Ophthalmol 1973;89:103-5.  Back to cited text no. 15
van Bijsterveld OP. Diagnostic tests in the Sicca syndrome. Arch Ophthalmol 1969;82:10-4.  Back to cited text no. 16
Guillemin I, Begley C, Chalmers R, Baudouin C, Arnould B. Appraisal of patient-reported outcome instruments available for randomized clinical trials in dry eye: Revisiting the standards. Ocul Surf 2012;10:84-99.  Back to cited text no. 17
Abetz L, Rajagopalan K, Mertzanis P, Begley C, Barnes R, Chalmers R, et al. Development and validation of the impact of dry eye on everyday life (IDEEL) questionnaire, a patient-reported outcomes (PRO) measure for the assessment of the burden of dry eye on patients. Health Qual Life Outcomes 2011;9:111.  Back to cited text no. 18
U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health. Guidance for industry: Patient-reported outcome measures: Use in medical product development to support labeling claims: Draft guidance. Health Qual Life Outcomes 2006;4:79.  Back to cited text no. 19
Grubbs JR Jr., Tolleson-Rinehart S, Huynh K, Davis RM. A review of quality of life measures in dry eye questionnaires. Cornea 2014;33:215-8.  Back to cited text no. 20
Muñoz B, West SK, Rubin GS, Schein OD, Quigley HA, Bressler SB, et al. Causes of blindness and visual impairment in a population of older Americans: The Salisbury Eye Evaluation Study. Arch Ophthalmol 2000;118:819-25.  Back to cited text no. 21
Uchino M, Yokoi N, Uchino Y, Dogru M, Kawashima M, Komuro A, et al. Prevalence of dry eye disease and its risk factors in visual display terminal users: The Osaka study. Am J Ophthalmol 2013;156:759-66.  Back to cited text no. 22
Begley CG, Caffery B, Nichols KK, Chalmers R. Responses of contact lens wearers to a dry eye survey. Optom Vis Sci 2000;77:40-6.  Back to cited text no. 23
Doughty MJ, Fonn D, Richter D, Simpson T, Caffery B, Gordon K, et al. Apatient questionnaire approach to estimating the prevalence of dry eye symptoms in patients presenting to optometric practices across Canada. Optom Vis Sci 1997;74:624-31.  Back to cited text no. 24
Xu L, Zhang W, Zhu XY, Suo T, Fan XQ, Fu Y, et al. Smoking and the risk of dry eye: A meta-analysis. Int J Ophthalmol 2016;9:1480-6.  Back to cited text no. 25


  [Table 1], [Table 2], [Table 3], [Table 4]

This article has been cited by
1 PM2.5 exposure increases dry eye disease risks through corneal epithelial inflammation and mitochondrial dysfunctions
Donghui Yu, Wenting Cai, Tianyi Shen, Yan Wu, Chengda Ren, Tingting Li, Chengyu Hu, Meijiang Zhu, Jing Yu
Cell Biology and Toxicology. 2023;
[Pubmed] | [DOI]
2 Prevalence of pesticide related occupational diseases among Indonesian vegetable farmers – A collaborative work
Sri Awalia Febriana, Miya Khalidah, Fariz Nurul Huda, Sri Sutarni, Indra Mahayana, Niken Indrastuti, Ismail Setyopranoto, Fajar Waskito, Suhardjo Prawiroranu, Ery Kus Dwianingsih, Rusdy Ghazali Malueka
Toxicology Reports. 2023; 10: 571
[Pubmed] | [DOI]
Asian Journal of Pharmaceutical and Clinical Research. 2023; : 83
[Pubmed] | [DOI]
4 Association of sunlight exposure with visual impairment in an Indian fishing community
Shwetha V Puthran, Sayantan Biswas, Siddharth K Karthikeyan, Jyothi Thomas
Indian Journal of Ophthalmology. 2023; 71(6): 2409
[Pubmed] | [DOI]
5 Prevalence and Risk Factors for Symptomatic Dry Eye Disease Based on McMonnies Questionnaire Among Medical Students, Saudi Arabia; a Cross-Sectional Study
Hanan M Aljammaz, Wijdan M Aleithan, Amal Mohammad Albalawi, Rabab T Aljayani, Rawabi T Aljayani, Manal M Aljammaz, Saad H Alenezi, Shaker Alreshidi, Faris Hashem, Naif M Alali, Hani B ALBalawi
International Journal of General Medicine. 2023; Volume 16: 2441
[Pubmed] | [DOI]
6 Digital eye strain: Time for a break
Parthasarathi Moulick
Journal of Ophthalmic Research and Practice. 2023; 1: 10
[Pubmed] | [DOI]
7 Ocular conjunctival microbiome profiling in dry eye disease: A case control pilot study
Noopur Gupta, Jyoti Chhibber-Goel, Yogita Gupta, Souvik Mukherjee, Arindam Maitra, Amit Sharma, Radhika Tandon
Indian Journal of Ophthalmology. 2023; 71(4): 1574
[Pubmed] | [DOI]
8 Study of dry eye syndrome: Focus on causative factors, treatment modalities, quality of life, and preservatives used in eye drops
Pratham M Raval, Harsh H Patel, Dipali M Purohit, Reema M Raval, Shikha V Sood
Indian Journal of Ophthalmology. 2023; 71(4): 1587
[Pubmed] | [DOI]
9 Ocular surface immune cell diversity in dry eye disease
Archana Padmanabhan Nair, Sharon D’Souza, Pooja Khamar, Rudy M M A Nuijts, Swaminathan Sethu, Rohit Shetty
Indian Journal of Ophthalmology. 2023; 71(4): 1237
[Pubmed] | [DOI]
10 Ion channels in dry eye disease
Nikhil Ashok, Pooja Khamar, Sharon D’Souza, Marlies Gijs, Arkasubhra Ghosh, Swaminathan Sethu, Rohit Shetty
Indian Journal of Ophthalmology. 2023; 71(4): 1215
[Pubmed] | [DOI]
11 Resveratrol for dry eye disease – Hope or Hype?
Rohit Shetty, Parth D Joshi, Krithikaa Mahendran, Chaitra Jayadev, Debashish Das
Indian Journal of Ophthalmology. 2023; 71(4): 1270
[Pubmed] | [DOI]
12 Prevalence of dry eye, its categorization (Dry Eye Workshop II), and pathological correlation: A tertiary care study
Kriti Bhatt, Satyaprakash Singh, Kamaljeet Singh, Santosh Kumar, Kshama Dwivedi
Indian Journal of Ophthalmology. 2023; 71(4): 1454
[Pubmed] | [DOI]
13 Impact of salivary stimulation on tear film function in dry eye subjects
Anup Kumar Sah, S Aparna, D L Ashwini
Indian Journal of Ophthalmology. 2023; 71(4): 1643
[Pubmed] | [DOI]
14 Dry eye disease in diabetics versus non-diabetics: Associating dry eye severity with diabetic retinopathy and corneal nerve sensitivity
Mitali V Mangoli, Shivanand C Bubanale, BK Bhagyajyothi, Dhruv Goyal
Indian Journal of Ophthalmology. 2023; 71(4): 1533
[Pubmed] | [DOI]
15 Comparative evaluation of effectiveness of twenty versus fifty percent autologous serum eye drops in treatment of dry eye
Neha Kumari, Rakhi Kusumesh, Rekha Kumari, Bibhuti Prassan Sinha, Vivek Singh
Indian Journal of Ophthalmology. 2023; 71(4): 1603
[Pubmed] | [DOI]
16 Omega-3 fatty acids supplements for dry eye - Are they effective or ineffective?
Rahul Bhargava, Kankambari Pandey, Somesh Ranjan, Bhavya Mehta, Anu Malik
Indian Journal of Ophthalmology. 2023; 71(4): 1619
[Pubmed] | [DOI]
17 Tear film microbiome in Sjogren’s and non-Sjogren’s aqueous deficiency dry eye
Spandita Pal, Gorati Vani, Pragnya Rao Donthineni, Sayan Basu, Kotakonda Arunasri
Indian Journal of Ophthalmology. 2023; 71(4): 1566
[Pubmed] | [DOI]
18 Assessment of prevalence of dry eye among medical students using ocular surface disease index questionnaire – Is COVID-19 to be really blamed?
AR Aberame, Sulatha V Bhandary, Lavanya G Rao, Chandni Gupta
Indian Journal of Ophthalmology. 2023; 71(4): 1450
[Pubmed] | [DOI]
19 Evaluation of post-operative dry eye in upper and lower eyelid reconstruction: A cross-sectional study
Purban Ganguly, Jit Bhunia, Kalishankar Das, Asim K Ghosh, Sumana Chatterjee, Debadyuti Chatterjee, Dichen W Bhutia, Angana S Ray, Asif Ayub
Indian Journal of Ophthalmology. 2023; 71(4): 1561
[Pubmed] | [DOI]
20 Type 1–type 2 interferon imbalance in dry eye disease
Trailokyanath Panigrahi, Sharon D’Souza, Vishnu Suresh Babu, Mor M Dickman, Rudy M M A Nuijts, Swaminathan Sethu, Rohit Shetty
Indian Journal of Ophthalmology. 2023; 71(4): 1526
[Pubmed] | [DOI]
21 Tear biomarkers in dry eye disease: Progress in the last decade
Nimisha R Kumar, Machiraju Praveen, Raghav Narasimhan, Pooja Khamar, Sharon D’Souza, Abhijit Sinha-Roy, Swaminathan Sethu, Rohit Shetty*, Arkasubhra Ghosh*
Indian Journal of Ophthalmology. 2023; 71(4): 1190
[Pubmed] | [DOI]
22 Evaluation of Prevalence and Associated Factors of Dry Eye Syndrome among Medical Students Exposed to Visual Display Terminal in Health Campus, Universiti Sains Malaysia
Patricia Ann John, Adil Hussein, Khairy Shamel Sonny Teo
Malaysian Journal of Medicine and Health Sciences. 2023; 19(3): 45
[Pubmed] | [DOI]
23 Prevalence and risk factors associated with dry eye disease among adults in a population-based setting in South-West Nigeria
AO Betiku, OO Oduyoye, OO Jagun, OS Olajide, SO Adebusoye, UO Aham-Onyebuchi
Nigerian Journal of Clinical Practice. 2022; 25(3): 354
[Pubmed] | [DOI]
24 Prevalence, Severity, and Treatment Outcomes of Meibomian Gland Dysfunction in Patients With Dry Eye Symptoms at a Tertiary Care Center in South India
Jayanti Singh, Yamini Priya, Vivek Bhat
Cureus. 2022;
[Pubmed] | [DOI]
25 Dry eye disease related to digital screen exposure in medical students
Alka Tripathi, Richa Agarwal, Pradip Kharya
The Pan-American Journal of Ophthalmology. 2022; 4(1): 35
[Pubmed] | [DOI]
26 Understanding and Optimizing Ocular Biometry for Cataract Surgery in Dry Eye Disease: A Review
Ananya Sudhir Nibandhe, Pragnya Rao Donthineni
Seminars in Ophthalmology. 2022; : 1
[Pubmed] | [DOI]
27 Tear film breakup time-based dry eye disease detection using convolutional neural network
Aditi Haresh Vyas, Mayuri A. Mehta, Ketan Kotecha, Sharnil Pandya, Mamoun Alazab, Thippa Reddy Gadekallu
Neural Computing and Applications. 2022;
[Pubmed] | [DOI]
28 Determining the effect of climate and profession on dry eye disease: A prevalence study among young males in north, north-west and central India
P.K. Chaturvedi, Jaya Kaushik, Vijay Mathur, Pradeep Kumar, Neha Chauhan
Medical Journal Armed Forces India. 2022;
[Pubmed] | [DOI]
29 Occupational ocular health problems among marble workers at Shaq El Tho’ban industrial area in Egypt
Enjy A. E. Khorshed, Safaa A. El-Naggar, Samia S. El-Gohary, Ahmed M. B. Awad, Amani S. Ahmed
Environmental Science and Pollution Research. 2022; 29(25): 37445
[Pubmed] | [DOI]
30 Trends in Diagnosed Dry Eye Disease Incidence, 2001 to 2015: A Nationwide Population-Based Study in Taiwan
I-Chan Lin, Yu-Kai Kuo, Hung-Yi Liu, Li-Nien Chien
Cornea. 2022; 41(11): 1372
[Pubmed] | [DOI]
31 Review on the possible pathophysiological mechanisms underlying visual display terminal-associated dry eye disease
Ketil Fjærvoll, Haakon Fjærvoll, Morten Magno, Sara Tellefsen Nøland, Darlene A. Dartt, Jelle Vehof, Tor P. Utheim
Acta Ophthalmologica. 2022;
[Pubmed] | [DOI]
32 Association of dry eye disease with smoking: A systematic review and meta-analysis
MuhammadAli Tariq, Hamza Amin, Bilal Ahmed, Uzair Ali, Ashar Mohiuddin
Indian Journal of Ophthalmology. 2022; 70(6): 1892
[Pubmed] | [DOI]
Suranjan Saha, Aparna Mandal, Sohel Mamud
[Pubmed] | [DOI]
Arul Malar, J. Arumaikannu
[Pubmed] | [DOI]
35 Factors influencing the clinical outcomes of intense pulsed light for meibomian gland dysfunction
Chen Chen, Di Chen, Yu-yu Chou, Qin Long
Medicine. 2021; 100(49): e28166
[Pubmed] | [DOI]
Souvik Ganguly, Sheuli Kumar, Sambuddha Ghosh, Debarshi Jana
[Pubmed] | [DOI]
37 Prevalence of symptoms of dry eye disease in an urban Indian population
Samrat Chatterjee, Deepshikha Agrawal, Gul Sanowar, Rushi Kandoi
Indian Journal of Ophthalmology. 2021; 69(5): 1061
[Pubmed] | [DOI]
38 Impact of the use of digital devices on eyes during the lockdown period of COVID-19 pandemic
Ugam Usgaonkar, SimranRajan Shet Parkar, Aksha Shetty
Indian Journal of Ophthalmology. 2021; 69(7): 1901
[Pubmed] | [DOI]
39 Efficacy of blink software in improving the blink rate and dry eye symptoms in visual display terminal users – A single-blinded randomized control trial
DL Ashwini, RameshS Ve, Daniela Nosch, Natoya Wilmot
Indian Journal of Ophthalmology. 2021; 69(10): 2643
[Pubmed] | [DOI]
40 Short tear film breakup time-type of dry eye in India
Samrat Chatterjee, Deepshikha Agrawal
Indian Journal of Ophthalmology. 2021; 69(12): 3463
[Pubmed] | [DOI]
41 Association between asthma and dry eye disease: a meta-analysis based on observational studies
Qun Huang, Yanlin Zheng, Chuantao Zhang, Wanjie Wang, Tingting Liao, Xili Xiao, Jing Wang, Juan Wang
BMJ Open. 2021; 11(12): e045275
[Pubmed] | [DOI]
42 Comparison of efficacy of trehalose-based eye drops versus topical 0.1% Hyaluronic Acid for management of clinically significant dry eye using non-invasive investigational modalities
Sheetal Brar, Hemanth Reddy Vanga, Sri Ganesh
International Ophthalmology. 2021; 41(10): 3349
[Pubmed] | [DOI]
43 Prevalence and associated risk factors of symptomatic dry eye in Ghana: A cross-sectional population-based study
Emmanuel Kobia-Acquah, Stephen Ankamah-Lomotey, Ebenezer Owusu, Sedinam Forfoe, Joseph Bannor, Joana Abokoma Koomson, Martin Opoku, Daniel Mensah Dzikpo, Derrick Nii Okaikwei Mensah, Jedidiah N. Amonoo, Prince Kwaku Akowuah
Contact Lens and Anterior Eye. 2021; 44(6): 101404
[Pubmed] | [DOI]
44 Phenotypic and transcriptomic changes in the corneal epithelium following exposure to cigarette smoke
Mengyi Jin, Yanzi Wang, Xiaoya An, Honghua Kang, Yixin Wang, Guoliang Wang, Yang Gao, Shuiping Wu, Peter S. Reinach, Zuguo Liu, Yuhua Xue, Cheng Li
Environmental Pollution. 2021; 287: 117540
[Pubmed] | [DOI]
45 Demographic and lifestyle risk factors of dry eye disease subtypes: A cross-sectional study
James S. Wolffsohn, Michael T.M. Wang, Maria Vidal-Rohr, Francesco Menduni, Sandeep Dhallu, Tugce Ipek, Duygu Acar, Alberto Recchioni, Alex France, Alec Kingsnorth, Jennifer P. Craig
The Ocular Surface. 2021; 21: 58
[Pubmed] | [DOI]
46 Protective effects of low-molecular-weight components of adipose stem cell-derived conditioned medium on dry eye syndrome in mice
Yuan-Chieh Lee, Li-Yi Sun, Jia-Rong Zhang
Scientific Reports. 2021; 11(1)
[Pubmed] | [DOI]
47 The association between visual display terminal use and dry eye: a review
Haakon Fjærvoll, Ketil Fjærvoll, Morten Magno, Emily Moschowits, Jelle Vehof, Darlene A. Dartt, Tor P. Utheim
Acta Ophthalmologica. 2021;
[Pubmed] | [DOI]
48 The global prevalence of dry eye disease: A Bayesian view
Eric B Papas
Ophthalmic and Physiological Optics. 2021; 41(6): 1254
[Pubmed] | [DOI]
49 The Association between Dry Eye Disease and Depression, Anxiety, and Stress among Saudi Arabian Adults
Danah Alrajhi, Rahaf Almutairi, Basma Alturki, Atheer Almutairi, Faris Binyousef, Shahad Alruwaili, Dalal Alessa
Open Journal of Ophthalmology. 2021; 11(04): 266
[Pubmed] | [DOI]
50 Aydintepe’de yasayan bireylerde göz kurulugu sikliginin ve risk faktörlerinin incelenmesi
Balikesir Health Sciences Journal. 2021;
[Pubmed] | [DOI]
51 Distribution and Correlation of Ocular Surface Disease Index Scores in a Non-Clinical Population: The Karachi Ocular Surface Disease Study
Nauman Hashmani, Faizan Ghulam Mustafa, Muhammad Ali Tariq, Syed Farjad Ali, Fakiha Bukhari, Abdul Sami Memon, Sharif Hashmani
Cureus. 2020;
[Pubmed] | [DOI]
52 Meibomian Gland Dysfunction in a Hospital-Based Population in Central India
Samrat Chatterjee, Deepshikha Agrawal, Arpit Sharma
Cornea. 2020; 39(5): 634
[Pubmed] | [DOI]
53 Association of dry eye disease and sun exposure in geographically diverse adult (=40 years) populations of India: The SEED (sun exposure, environment and dry eye disease) study - Second report of the ICMR-EYE SEE study group
Radhika Tandon, Praveen Vashist, Noopur Gupta, Vivek Gupta, Pranita Sahay, Dipali Deka, Sachchidanand Singh, K. Vishwanath, G.V.S. Murthy
The Ocular Surface. 2020; 18(4): 718
[Pubmed] | [DOI]
54 Ocular conditions and dry eye due to traditional and new forms of smoking: A review
Dimitra Makrynioti, Zoi Zagoriti, Constantinos Koutsojannis, Philip B. Morgan, George Lagoumintzis
Contact Lens and Anterior Eye. 2020; 43(3): 277
[Pubmed] | [DOI]
55 Prevalence of dry eyes in patients with Type-2 diabetes mellitus
Rakesh Goud, Manvi Aggarwal, O K Radhakrishnan, Priyanka Mantri, Arpit Shah
Indian Journal of Clinical and Experimental Ophthalmology. 2020; 6(2): 286
[Pubmed] | [DOI]
56 Dry eye disease in India
Samrat Chatterjee, Deepshikha Agrawal, Arpit Sharma
Indian Journal of Ophthalmology. 2020; 68(7): 1499
[Pubmed] | [DOI]
57 Prevalence of dry eye in computer users
B K. S Reshma, Safiya Iram
IP International Journal of Ocular Oncology and Oculoplasty. 2020; 6(2): 95
[Pubmed] | [DOI]
58 The applications of androgen in the treatment of dry eye disease: a systematic review of clinical studies
Lixiang Wang, Yingping Deng
Endocrine Journal. 2020; 67(9): 893
[Pubmed] | [DOI]
Neelima Mehrotra, Amrita Bajpai Mishra, Alia Yamin, Ruchi Saxena, Ashwani Srivastava
[Pubmed] | [DOI]
Monica Mahesha, Tanvi Patole
[Pubmed] | [DOI]
61 Dry eyes, gritty or not?
R Deborah Rinita, G S Srinivasan
Indian Journal of Clinical and Experimental Ophthalmology. 2020; 6(4): 637
[Pubmed] | [DOI]
62 Prevalence of Dry Eye Disease in Africa: A Systematic Review and Meta-analysis
Prince K. Akowuah, Emmanuel Kobia-Acquah
Optometry and Vision Science. 2020; 97(12): 1089
[Pubmed] | [DOI]
63 Association between asthma with dry eye disease
Qun Huang, Yang Yang, Tingting Liao, Chuantao Zhang, Yanlin Zheng, Wanjie Wang, Xili Xiao, Jing Wang, Juan Wang
Medicine. 2020; 99(41): e22519
[Pubmed] | [DOI]
64 Gout as a Risk Factor for Dry Eye Disease: A Population-Based Cohort Study
Chia-Yi Lee, Hung-Chi Chen, Chi-Chin Sun, Hung-Yu Lin, Ko-Hsiu Lu, Jing-Yang Huang, Chao-Bin Yeh, Shun-Fa Yang
Journal of Clinical Medicine. 2019; 8(1): 62
[Pubmed] | [DOI]
65 Influence of Prolonged Visual Display Terminal Use and Exercise on Physical and Mental Conditions of Internet Staff in Hangzhou, China
Xiao Cheng, Mengna Song, Jingxia Kong, Xinglin Fang, Yuqing Ji, Meibian Zhang, Hongmei Wang
International Journal of Environmental Research and Public Health. 2019; 16(10): 1829
[Pubmed] | [DOI]
66 Incidence, demographics, types and risk factors of dry eye disease in India: Electronic medical records driven big data analytics report I
Pragnya Rao Donthineni, Priyanka Kammari, Swapna S. Shanbhag, Vivek Singh, Anthony Vipin Das, Sayan Basu
The Ocular Surface. 2019; 17(2): 250
[Pubmed] | [DOI]
67 The perils and pitfalls of big data analysis in medicine
C.J. Puranik, Sreenivasa Rao, S. Chennamaneni
The Ocular Surface. 2019; 17(4): 838
[Pubmed] | [DOI]


    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

  In this article
Article Tables

 Article Access Statistics
    PDF Downloaded1089    
    Comments [Add]    
    Cited by others 67    

Recommend this journal